Enhancer ID: | E_01_0339 |
Species: | human |
Position : | chr3:181709342-181711342 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Mammary cancer |
Pubmed ID: | 30606720 |
Enhancer experiment: | PCR?Western blot?RNA-seq |
Enhancer experiment description: | In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Sox2 Srr2 enhancer |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Sox2 Srr2 enhancer |
TF name : | SOX2(ANOP3,MCOPS3) |
TF experiment: | PCR?Western blot?RNA-seq |
TF experiment description: | In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Sox2 Srr2 enhancer |
Enhancer function : | In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Sox2 Srr2 enhancer |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Sox2 Srr2 enhancer |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
SOX2 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
SOX2 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
SOX2 | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | reactome | 10 |
SOX2 | Transcriptional regulation of pluripotent stem cells | reactome | 28 |
SOX2 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
SOX2 | Hs_Dopaminergic_Neurogenesis_WP2855_87239 | wikipathways | 19 |
SOX2 | Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 | wikipathways | 12 |
SOX2 | Hs_Mesodermal_Commitment_Pathway_WP2857_87780 | wikipathways | 47 |
SOX2 | Hs_Ectoderm_Differentiation_WP2858_89329 | wikipathways | 56 |